Companies / BOC Sciences / Crenezumab
BOC Sciences

Crenezumab | BOC Sciences

Crenezumab is a humanized monoclonal antibody that targets _-amyloid oligomers. Crenezumab has been investigated for the treatment of early AD.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.